Community Fairbanks Recovery Center

0.000
Contact Information
8102 Clearvista Parkway , Indianapolis, Indiana 46256, United States
Detailed Information

Community Fairbanks Recovery Center

    Services:
    Facility Operation (e.g., Private, Public)

    • Private non-profit organization

    Detoxification (medical withdrawal) Services

    • Methamphetamines detoxification
    • Cocaine Detoxification
    • Opioids detoxification
    • Medication routinely used during detoxification
    • Benzodiazepines Detoxification
    • Alcohol Detoxification

    Language Services

    • Sign language services for the deaf and hard of hearing

    Testing

    • Testing for Hepatitis C (HCV)
    • HIV testing
    • TB screening
    • STD testing
    • Testing for Hepatitis B (HBV)
    • Drug or alcohol urine screening
    • Drug and alcohol oral fluid testing
    • Breathalyzer or blood alcohol testing

    External Opioid Medications Source

    • Other contracted prescribing entity
    • No formal relationship with prescribing entity
    • In-network prescribing entity

    Facility Smoking Policy

    • Smoking permitted in designated area

    Ancillary Services

    • Social skills development
    • Case management service
    • Acupuncture

    Assessment/Pre-treatment

    • Comprehensive mental health assessment
    • Screening for tobacco use
    • Comprehensive substance use assessment
    • Complete medical history/physical exam
    • Screening for mental disorders
    • Professional interventionist/educational consultant
    • Screening for substance use

    Transitional Services

    • Discharge Planning
    • Naloxone and overdose education
    • Aftercare/continuing care
    • Outcome follow-up after discharge

    Type of Alcohol Use Disorder Treatment

    • Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
    • This facility administers/prescribes medication for alcohol use disorder

    Pharmacotherapies

    • Acamprosate (Campral®)
    • Naltrexone (extended-release, injectable)
    • Nicotine replacement
    • Clonidine
    • Buprenorphine without naloxone
    • Buprenorphine with naloxone
    • Medication for mental disorders
    • Buprenorphine sub-dermal implant
    • Buprenorphine (extended-release, injectable)
    • Disulfiram
    • Naltrexone (oral)
    • Non-nicotine smoking/tobacco cessation

    Type of Care

    • Detoxification
    • Substance use treatment

    Special Programs/Groups Offered

    • Adult women
    • Clients who have experienced trauma
    • Adolescents
    • Adult men

    Exclusive Services

    • Specially designed program for DUI/DWI clients

    License/Certification/Accreditation

    • State Substance use treatment agency
    • The Joint Commission
    • State department of health
    • Drug Enforcement Agency (DEA)
    • State mental health department

    Education and Counseling Services

    • Substance use disorder education
    • Family counseling
    • Marital/couples counseling
    • Hepatitis education, counseling, or support
    • Smoking/vaping/tobacco cessation counseling
    • Individual counseling
    • Group counseling
    • HIV or AIDS education, counseling, or support
    • Health education services other than HIV/AIDS or hepatitis

    Type of Opioid Treatment

    • Prescribes naltrexone
    • Relapse prevention with naltrexone
    • Buprenorphine maintenance
    • Maintenance service with medically supervised withdrawal after stabilization
    • Buprenorphine detoxification
    • Prescribes buprenorphine
    • Lofexidine or Clonidine detoxification
    • Accepts clients using MAT but prescribed elsewhere

    External Source of Medications Used for Alcohol Use Disorder Treatment

    • No formal relationship with prescribing entity
    • In-network prescribing entity
    • Other contracted prescribing entity

    Recovery Support Services

    • Recovery coach
    • Housing services
    • Mentoring/peer support
    • Self-help groups

    Age Groups Accepted

    • Children/Adolescents

    Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

    • Hospital inpatient/24-hour hospital inpatient
    • Residential/24-hour residential
    • Regular outpatient treatment
    • Outpatient methadone/buprenorphine or naltrexone treatment
    • Hospital inpatient detoxification
    • Intensive outpatient treatment
    • Short-term residential
    • Hospital inpatient treatment
    • Outpatient day treatment or partial hospitalization
    • Long-term residential
    • Outpatient

    Payment/Insurance/Funding Accepted

    • Medicare
    • Federal, or any government funding for substance use treatment programs
    • SAMHSA funding/block grants
    • Federal military insurance (e.g., TRICARE)
    • Private health insurance
    • Cash or self-payment
    • State-financed health insurance plan other than Medicaid
    • Medicaid

    Gender Accepted

    • Male
    • Female

    Opioid Medications used in Treatment

    • Naltrexone used in Treatment
    • Buprenorphine used in Treatment

    Facility Vaping Policy

    • Vaping not permitted

    Treatment Approaches

    • Brief intervention
    • 12-step facilitation
    • Telemedicine/telehealth therapy
    • Relapse prevention
    • Trauma-related counseling
    • Substance use disorder counseling
    • Cognitive behavioral therapy
    • Motivational interviewing
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm